David C. Glahn, PhD, Professor of Psychiatry and Professor of Psychology at Yale, was the Vice Chair of the 2017 Gordon Research Conference in Cognitive Dysfunction in Brain Diseases held June 11-16, 2017, at The Chinese University of Hong Kong.
The meeting attracted over 100 experts in the field from 14 countries. It focused on the mechanisms and therapeutic targets for cognitive deficits in neurologic and psychiatric diseases, and covered topics like assessment techniques and innovative lifestyle modulators.
As Vice Chair, Glahn helped organize the meeting and select speakers. He also ran the business meeting. He expects to serve as one of two Co-Chairs for the Spring 2019 meeting.
Gordon Research Conferences organizes international scientific conferences to advance the frontiers of scientific research in the biological, chemical, and physician sciences, and their related technologies.
Glahn is Co-Director of the Neurocognition, Neurocomputation and Neurogenetics (n3) Division at Yale and is Principal Investigator at the Glahn Lab, which seeks to identify and characterize risk genes for psychotic and affective disorders like depression, bipolar disorder, and schizophrenia. The lab also seeks to specify genetic influences on normal variation of in-vivo measures of brain structure and function and cognitive ability.
Glahn has published over 200 papers and reviews in leading scientific journals, and has received numerous awards for his work, including the 2016 Joel Elkes Research Award from the American College of Neuropsychopharmacology (ACNP). The award was given in recognition of Glahn’s outstanding clinical contributions to neuropsychopharmacology.